Vertex Pharmaceuticals (VRTX) Leases (2016 - 2025)
Historic Leases for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Q3 2025 value amounting to $1.6 billion.
- Vertex Pharmaceuticals' Leases rose 1401.76% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 1401.76%. This contributed to the annual value of $1.4 billion for FY2024, which is 36212.53% up from last year.
- Vertex Pharmaceuticals' Leases amounted to $1.6 billion in Q3 2025, which was up 1401.76% from $1.3 billion recorded in Q2 2025.
- Vertex Pharmaceuticals' Leases' 5-year high stood at $1.6 billion during Q3 2025, with a 5-year trough of $293.6 million in Q4 2023.
- Moreover, its 5-year median value for Leases was $336.3 million (2023), whereas its average is $622.8 million.
- In the last 5 years, Vertex Pharmaceuticals' Leases crashed by 1548.65% in 2023 and then skyrocketed by 36212.53% in 2024.
- Over the past 5 years, Vertex Pharmaceuticals' Leases (Quarter) stood at $400.1 million in 2021, then decreased by 13.17% to $347.4 million in 2022, then decreased by 15.49% to $293.6 million in 2023, then soared by 362.13% to $1.4 billion in 2024, then grew by 17.32% to $1.6 billion in 2025.
- Its Leases was $1.6 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.